TY  - CHAP
M1  - Book, Section
TI  - Drug-Induced Kidney Disease
A1  - Wells, Barbara G.
A1  - DiPiro, Joseph T.
A1  - Schwinghammer, Terry L.
A1  - DiPiro, Cecily V.
PY  - 2017
T2  - Pharmacotherapy Quick Guide
AB  - Table  Graphic  Jump  Location|Download  (.pdf)|PrintTABLE  A6–1:  Drug-Induced  Kidney  Structural–Functional  AlterationsTubular  epithelial  cell  damageAcute  tubular  necrosisAminoglycoside  antibioticsRadiographic  contrast  mediaCisplatin,  carboplatinAmphotericin  BCyclosporine,  tacrolimusAdefovir,  cidofovir,  tenofovirPentamidineFoscarnetZoledronateOsmotic  nephrosisMannitolDextranIV  immunoglobulinHemodynamically  mediated  kidney  injuryAngiotensin-converting  enzyme  inhibitorsAngiotensin  II  receptor  blockersNonsteroidal  anti-inflammatory  drugs  (NSAIDs)Cyclosporine,  tacrolimusOKT3Obstructive  nephropathyCrystal  nephropathyAcyclovirSulfonamidesIndinavirFoscarnetMethotrexateNephrolithiasisSulfonamidesTriamtereneIndinavirNephrocalcinosisOral  sodium  phosphate  solutionGlomerular  diseaseMinimal  change  diseaseNSAIDs,  COX-2  inhibitorsLithiumPamidronateInterferon-α  and  -βMembranous  diseaseNSAIDsPenicillamineCaptoprilFocal  Segmental  GlomerulosclerosisPamidronateInterferon-α  and  -βLithiumSirolimusAnabolic  steroidsTubulointerstitial  diseaseAcute  allergic  interstitial  nephritisPenicillinsCiprofloxacinNSAIDs,  cyclooxygenase-2  inhibitorsProton  pump  inhibitorsLoop  diureticsChronic  interstitial  nephritisCyclosporineLithiumAristolochic  acidPapillary  necrosisNSAIDs,  combined  phenacetin,  aspirin,  and  caffeine  analgesicsRenal  vasculitis,  thrombosis,  and  cholesterol  emboliVasculitis  and  thrombosisHydralazinePropylthiouracilAllopurinolPenicillamineGemcitabineMitomycin  CMethamphetaminesCyclosporine,  tacrolimusAdalimumabBevacizumabCholesterol  emboliWarfarinThrombolytic  agents  
SN  - 
PB  - McGraw-Hill Education
CY  - New York, NY
Y2  - 2024/04/19
UR  - accesspharmacy.mhmedical.com/content.aspx?aid=1144733307
ER  -